---
title: Applying Global Sensitivity Analysis to Improve Computational Efficiency in Physiological-Based Pharmacokinetic Model
subtitle: "---"
author: "**Nan-Hung Hsieh, PhD**"
date: .small[Postdoctoral Research Associate @ Department of Veterinary Integrative Biosciences]
output: 
  xaringan::moon_reader:
    lib_dir: libs
    css: ["default", "tamu.css", "tamu-fonts.css"]
    nature:
      highlightLines: true
---

# About Me

### PhD in Bioenvironmental Systems Engineering @ National Taiwan University

```{r setup, include=FALSE}
htmltools::tagList(rmarkdown::html_dependency_font_awesome())
```

--

**My Research:** .bolder[Computational Toxicology] & .bolder[Risk Assessment]

--

**My Daily Work:**

.center[
<img src="http://whatmyfriendsthinkido.net/wp-content/uploads/2012/05/what-my-friends-think-I-do-what-i-actually-do-computer-programming.png" height="360px" />
]

---

# What is Pharmacokinetics (PK)

.large[
Pharmacokinetics is the study of the fate of chemical in a living organism through .bolder[ADME] process (**absorption**, **distribution**, **metabolism**, and **elimination**).
]

.center[![](https://media.springernature.com/original/springer-static/image/art%3A10.1007%2Fs00535-015-1061-4/MediaObjects/535_2015_1061_Fig1_HTML.gif)

.large[
**"PK"** focus on .bolder[DOSE] to .bolder[CONCENTRATION]
]
]

???
Pharmacokinetics is the application of kinetics to drug. Kinetics is that branch of knowledge which involves the change of one or more variables as a function of time. 

---

background-image: url(http://www.mdpi.com/mca/mca-23-00027/article_deploy/html/images/mca-23-00027-g006.png)
background-size: 320px
background-position: 88% 34%

# Pharmacokinetics Model

Pharmacokinetic modelling is performed to .large[.bolder["predict"]] the exposure  concentration in the **concentration-time** graph by constructing the **compartmental model** or non-compartmental model.

<br/>

<br/>

.center[
<img src="https://ars.els-cdn.com/content/image/1-s2.0-S1021949816301946-fx1_lrg.jpg" height="330px" />
]

???
It quantify the fate of drug, which is ADME
The top-right diagram is a simple example of PK model 

---

## Physiological-Based Pharmacokinetic (PBPK) Model

Mathematically transcribing .bolder[anatomical, physiological, physical, and chemical] descriptions of the phenomena involved in the complex .bolder[ADME] processes.

.shrink[
![](http://pharmguse.net/pkdm/pbpm.jpg)
]


---

background-image: url(https://wol-prod-cdn.literatumonline.com/cms/attachment/87cce77b-8dd4-4928-869f-b230e0cffcc4/psp412134-fig-0003-m.jpg)
background-size: 540px
background-position: 90% 90%

# Why Pharmacokinetic Modeling

- **Pharmaceutical research**

- **Drug development**

- **Health risk assessment**

        .  
        .  
        .  

---

# Challenge

.large[Currently, the **Bayesian Markov chain Monte Carlo algorithm** is a effective way to do PBPK model calibration. ]

.xlarge[.bolder[BUT]]

--

.large[
This method often have challenges to reach **"convergence"** with acceptable computational times  .bolder[(More parameters, More time!)]
]

.right[![](https://slides.yihui.name/gif/questions.gif)]

---

class: middle, center

## Sometimes, the result is bad ...

![](https://slides.yihui.name/gif/dump-computer.gif)

---

# Optimal Solution - Parameter Fixing 

.large[We usually fix the **"possible"** non-influential model parameters through **"expert judgment"**.]

.xlarge[.bolder[BUT]]

--

.large[This approach might cause **"bias"** in parameter estimates and model predictions.]

.center[![](http://reliawiki.org/images/3/35/Doe34.png)]

---

# Propose solution for parameter fixing 

## "Global" Sensitivity Analysis

![](https://i.imgur.com/FjJIl7s.png)

---

# What/Why Global Sensitivity Analysis?

**"Global"** sensitivity analysis calculates the contribution from the variety of all model parameters, including 

- .bolder[Single parameter effects]
- .bolder[Multiple parameter interactions]

.pull-left[
**Local** (One-at-a-time)
![](http://evelynegroen.github.io/assets/images/fig11local.jpg)
]

.pull-right[
**Global** (All-at-a-time)
![](http://evelynegroen.github.io/assets/images/fig2global.jpg)
]

--

.center[**Global sensitivity analysis is good at** .bolder[parameter fixing]]

---

class: middle

# Hypothesis

.large[
.bolder[Global Sensitivity Analysis] can provide a systematic method to ascertain which PBPK model parameters have **negligible influence** on model outputs and can be fixed to improve computational speed in Bayesian parameter estimation with **minimal bias**.
]


.highlight[

**Question:**

1. .large[What] is the best sensitivity analysis algorithm for PBPK model?

2. .large[Dose] global sensitivity analysis better than "expert decision"?

3. .large[Can] global sensitivity analysis provide the effective way in model calibration?

]

---

background-image: url(https://i.imgur.com/JjqgWwg.gif)
background-size: 320px
background-position: 90% 80%

# Materials

### PBPK Model ([Zurlinden and Reisfeld, 2016](https://link.springer.com/article/10.1007%2Fs13318-015-0253-x)): 

The simulation of the disposition of .bolder[acetaminophen (APAP)] and two of its key metabolites, .bolder[APAP-glucuronide (APAP-G)] and .bolder[APAP-sulfate (APAP-S)], in plasma, urine, and several pharmacologically and toxicologically relevant tissues.

<img src="https://i.imgur.com/uSCphVE.gif" height="340px" />

.footnote[
APAP is used to treat mild to moderate pain (from headaches, toothaches, backaches, cold/flu aches and pains) and to reduce fever.
]


---

# Materials

### Experiment Data: 

Eight studies (n = 71) with single oral dose and three different given doses.

```{r, echo=F, eval=T}
Study <- c(1:8)
Dose <- c("325 mg", "1000 mg", "1000 mg", "1000 mg", "20 mg/kg", "20 mg/kg", "20 mg/kg", "20 mg/kg")
Subject <- c("8","6","5","12","8","6","11","9")
df <- data.frame(Study, Dose, Subject)
names(df) <- c("Study", "Dose", "No. of Subject")
knitr::kable(df, format = 'html', align=c("l","c","c"))
```

---

# Materials

### Experiment Data: 

Eight studies (n = 71) with single oral dose and three different given doses.

.center[
<img src="https://i.imgur.com/wuYl7Bk.png" height="420px" />
]

---

# Materials

### Sensitivity Analysis: 

**Local:** 

- Morris's algorithm

**Global:**  

- Extended Fourier Amplitude Sensitivity Testing (EFAST)

- Jansen's algorithm 

- Owen's algorithm


---

class: center

# Sensitivity Analysis (SA) Workflow


.large[Reproduce result from original paper (21 parameters)] 


<i class="fa fa-arrow-down"></i>


.large[Full model calibration (58 parameters)] 


<i class="fa fa-arrow-down"></i>

--

.highlight[
.large[Sensitivity Analysis using different sensitivity analysis algorithms]  
**Compare the .bolder[time-cost, stability, and consistency] under the same sample number (Q1)**
]

<i class="fa fa-arrow-down"></i>

.highlight[
.large[Model calibration by SA-judged influential parameters]   

**Compare the .bolder[model performance] in accuracy and precision (Q2)**  
**Compare the .bolder[time-cost] in model calibration (Q3)**
]

---

## Q1: What is the best SA algorithm for PBPK model?

--

### Time-spend in SA (min)

.center[.xlarge[
Morris (2.4) < .bolder[EFAST (19.8)] $\approx$ Jansen (19.8) < Owen (59.4)
]]

### Stability in SA (variation of sensitivity index)

.center[.xlarge[
Morris (2.3%) < .bolder[EFAST (5.3%)] < Jansen (8.0%) <  Owen (15.9%)
]]

### Consistency in parameter detecting (correlation across 4 methods)

.center[.xlarge[
.bolder[EFAST] $\approx$ Jansen $\approx$  Owen > Morris
]]

--

.large[
.center[
.highlight[
**Ans 1: .bolder[EFAST] gives the best result to detect parameter impact.**
]
We found **20** influential parameters by using EFAST.
]]



---

## Q2: Dose global SA better than "expert decision"?

--

- The .bolder[EFSAT] has better **precision** (high kurtosis) than expert decision
- The **accuracy** (residual mean $\approx$ 0) are very .bolder[similar] across three test methods

.center[
<img src="https://i.imgur.com/PKKfVDM.png" height="450px" />  
]

---

.center[
<img src="https://i.imgur.com/vtvoHAX.png" height="530px" />  
]

--

.center[
.highlight[
**Ans 2: .bolder[EFAST]  was more effective than "expert judgment” at identifying parameters that are influential, and led to a better fitted results.** 
]]

---

## Q3: Can global SA provide the effective way in model calibration?

--

- Summary of the time-cost for all model parameters (this study, 58), EFAST-judged parameters (this study, 20), and expert-judged parameters ([Zurlinden and Reisfeld, 2016](https://link.springer.com/article/10.1007%2Fs13318-015-0253-x), 21)

```{r, echo=F, eval=T}
x <- c("All model parameters", "EFAST-judged parameters", "Expert-judged parameters")
y <- c("104.6 (0.96)", "42.1 (0.29)", "40.8 (0.18)")
df <- data.frame(x,y)
names(df) <- c("Parameter group","Time-cost in calibration (hr)")
knitr::kable(df, format = 'html', align=c("l","c"))
```

- All time-cost value are shown with mean and standard deviation (n = 10).

--

.center[
.highlight[
**Ans 3: Dimensionality reduction of PBPK model parameters by .bolder[EFAST] can substantially reduce computational time-cost while showing little change in model performance**. 
]]

---

# Take Home Message

.large[
If you want to do model calibration for PK or PBPK model, you can,
]

1. Use the .bolder[EFAST] to detect the **"influential"** model parameter.

1. Fix the **"non-influential"** parameters that were judged by .bolder[EFAST].

1. Conduct model calibration for only the **"influential"** parameters.

--

<br />

.large[
If you want more details, read this ... <i class="fa fa-smile-o"></i> 
]

Hsieh N-H, Reisfeld B, Bois FY and Chiu WA (2018) Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling. *Front. Pharmacol.* 9:588. doi: 10.3389/fphar.2018.00588   
[link](https://www.frontiersin.org/articles/10.3389/fphar.2018.00588/full)  

.right[![](https://www.frontiersin.org/areas/journals/images/about-open-access.png)]


---

class: inverse, center

## Acknowledgements

**Supervisor**  
.large[Weihsueh A. Chiu] 

**Principal investigator**  
.large[Brad Reisfeld] 

**Software**  
.large[Frederic Y. Bois]

**PBPK model**  
.large[Todd Zurlinden]

<br />

### Fouder

<img src="https://www.fda.gov/ucm/groups/fdagov-public/documents/image/ucm519147.png" height="80px" /> 

---

# Reference

**Model calibration technique**

Bois, F. Y. (2009). GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models. Bioinformatics 25, 1453–1454. doi: 10.1093/bioinformatics/btp162  
[link](https://doi.org/10.1093/bioinformatics/btp162)

**Idea of global SA-PBPK**

McNally, K., Cotton, R., and Loizou, G. D. (2011). A workflow for global sensitivity analysis of PBPK models. Front. Pharmacol. 2:31. doi: 10.3389/fphar.2011.00031   
[link](https://doi.org/10.3389/fphar.2011.00031)

**APAP-PBPK model details**

Zurlinden, T. J., and Reisfeld, B. (2016). Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach. Eur. J. Drug Metab. Pharmacokinet. 41, 267–280. doi: 10.1007/s13318-015-0253-x   
[link](https://doi.org/10.1007/s13318-015-0253-x)

---

# Image source

[My Daily Work](http://whatmyfriendsthinkido.net/)

[What is Pharmacokinetics](https://link.springer.com/article/10.1007/s00535-015-1061-4)

[Pharmacokinetics Model - 1](https://www.sciencedirect.com/science/article/pii/S1021949816301946#undfig1)

[Pharmacokinetics Model - 2](http://www.mdpi.com/2297-8747/23/2/27)

[Physiological-Based Pharmacokinetic (PBPK) Model](http://pharmguse.net/pkdm/prediction.html)

[Why Pharmacokinetics modeling](https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/psp4.12134)

[Optimal solution - Parameter Fixing](http://reliawiki.org/index.php/Statistical_Background_on_DOE)

["Global" Sensitivity Analysis](https://en.wikipedia.org/wiki/Sensitivity_analysis)

[What/Why Global Sensitivity Analysis?](http://evelynegroen.github.io/introduction/Introduction.html)

[GIF](https://yihui.name/)

---

# Thanks!

### More info: <i class="fa fa-home"></i> https://nanhung.me

### Slides at  

![](https://i.imgur.com/LRrz43H.png)

???

ENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDENDEND
